Cheyne Capital Management (UK)’s Alimera Sciences ALIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-4,867
Closed -$177K 35
2015
Q4
$177K Hold
4,867
0.1% 31
2015
Q3
$161K Hold
4,867
0.08% 39
2015
Q2
$336K Sell
4,867
-15,262
-76% -$1.05M 0.11% 77
2015
Q1
$1.51M Buy
20,129
+15,057
+297% +$1.18M 0.36% 33
2014
Q4
$422K Buy
+5,072
New +$412K 0.11% 49

Other funds holding ALIM

Cheyne Capital Management (UK)'s ALIM Position: Q1 2016 in Review

Cheyne Capital Management (UK) sold out of Alimera Sciences (ALIM) in Q1 2016, closing a stake of 4,867 shares — an estimated $177K sold.

Cheyne Capital Management (UK) first reported a position in ALIM in Q4 2014 and held it in 5 quarters. The position peaked at $1.51M in Q1 2015. 54 funds tracked by Wall St. Rank hold ALIM as of Q1 2016.

  • Cheyne Capital Management (UK) reported no remaining Alimera Sciences position as of Q1 2016 after selling out during the quarter.
  • Cheyne Capital Management (UK) sold 4,867 Alimera Sciences shares in Q1 2016, an estimated $177K.
  • Cheyne Capital Management (UK) first reported a position in Alimera Sciences in Q4 2014 and held it in 5 quarters.
  • Cheyne Capital Management (UK)'s Alimera Sciences position peaked at $1.51M in Q1 2015.
  • 54 funds tracked by Wall St. Rank held Alimera Sciences as of Q1 2016.

Based on Cheyne Capital Management (UK)'s 13F filing for Q1 2016, filed 18 Apr 2016.